What does it take to call it a pathogenic mutation?

Clinical Immunology

Volumn 128, Issue 3, 2008, Pages 285-286

  Fleisher, Thomas A ^a   Notarangelo, Luigi D ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRUTON TYROSINE KINASE;

AMINO ACID SUBSTITUTION; ANTIBODY RESPONSE; COMMON VARIABLE IMMUNODEFICIENCY; EDITORIAL; GENE MUTATION; HUMAN; INTESTINE INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECURRENT INFECTION; RESPIRATORY TRACT INFECTION; SKIN INFECTION; X LINKED AGAMMAGLOBULINEMIA;

ADULT; AGAMMAGLOBULINEMIA; B-LYMPHOCYTES; FAMILY; GENETIC DISEASES, X-LINKED; HUMANS; MALE; MUTATION, MISSENSE; PROTEIN-TYROSINE KINASES;

EID: 49149114620     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2008.04.013     Document Type: Editorial

References (12)

1. Graziani S., Di Matteo G., Benini L., Di Cesare S., Chiriaco M., Chini L., Chianca M., De Iorio F., La Rocca M., Iannini R., Corrente S., Rossi P., and Moschese V. Identification of a Btk mutation in a dysgammaglobulinemic patient with reduced B cells: XLA diagnosis or not?. Clin. Immunol. 128 (2008) 322-328
2. Bykowsky M.J., Haire R.N., Ohta Y., et al. Discordant phenotype in siblings with X-linked agammaglobulinemia. Am. J. Hum. Genet. 58 (1996) 477-483
3. Lopez-Granados E., Perez D., Ferreira C.A., Fontan C.G., and Garcia Rodriguez M.C. A genotype-phenotype correlation study in a group of 54 patients with X-linked agammaglobulinemia. J. Allergy Clin. Immunol. 116 (2005) 690-697
4. Wood P.M., Mayne A., Joyce H., Smith C.I., Granoff D.M., and Kumararatne D.S. A mutation in Bruton's tyrosine kinase as a cause of selective anti-polysaccharide antibody deficiency. J. Pediatr. 139 (2001) 148-151
5. Plebani A., Soresina A., Rondelli R., Amato G., Azzari C., Cardinale F., Cazzola G., Consolini R., De Mattia D., Dell'Erba G., Duse M., Fiorini M., Martino S., Martire B., Masi M., Monafo V., Moschese V., Notarangelo L., Orlandi P., Panei P., Pession A., Pietrogrande M., Pignata C., Quinti I., Ragno V., Rossi P., Sciotto A., Stabile A., Ugazio A., and and the Italian Pediatric Group for XLA-AIEOP. Clinical, immunological, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: an Italian multicenter study. Clin. Immunol. 104 (2002) 221-230
6. Conley M.E., Notarangelo L.D., and Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin. Immunol. 93 (1999) 190-197
7. Conley M.E., Farmer D.M., Dobbs A.K., Howard V., Aiba Y., Shurtleff S.A., and Kurosaki T. A minimally hypomorphic mutation in Btk resulting in reduced B cell numbers but no clinical disease. Clin. Exp. Immunol. 152 (2008) 39-44
8. Mooney S. Bioinformatics approaches and resources for single nucleotide polymorphism functional analysis. Briefing Bioinformatics 6 (2005) 44-56
9. Ng P.C., and Henikoff S. Accounting for human polymorphisms predicted to affect protein function. Genome Res. 12 (2002) 436-446
10. Perez de Diego R., Bravo J., Allende L.M., et al. Identification of novel non-pathogenic mutation in SH3 domain of Btk in an XLA patient. Mol. Immunol. 45 (2008) 301-303
11. Conley M.E., Parolini O., Rohrer J., and Campana D. X-linked agammaglobulinemia: new approaches to old questions based on the identification of the defective gene. Immunol. Rev. 138 (1994) 5-21
12. Broides A., Yang W., and Conley M.E. Genotype/phenotype correlations in X-linked agammaglobulinemia. Clin. Immunol. 118 (2006) 195-200